{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:18:47Z","timestamp":1793042327748,"version":"4.5.0"},"reference-count":154,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["1292393"],"award-info":[{"award-number":["1292393"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008376","name":"Helsingin ja Uudenmaan Sairaanhoitopiiri","doi-asserted-by":"publisher","award":["TYH2019311"],"award-info":[{"award-number":["TYH2019311"]}],"id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sigrid Juselius foundation","id":[{"id":"https:\/\/ror.org\/00ckakm23","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008487","name":"Sosiaali- ja Terveysministeri\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008487","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1038\/s41423-020-0388-9","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T08:02:47Z","timestamp":1583740967000},"page":"313-322","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":151,"title":["Physiology of gangliosides and the role of antiganglioside antibodies in human diseases"],"prefix":"10.1038","volume":"17","author":[{"given":"Gianni","family":"Cutillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Helena","family":"Saariaho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9142-501X","authenticated-orcid":false,"given":"Seppo","family":"Meri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,9]]},"reference":[{"key":"388_CR1","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1084\/jem.20142290","volume":"212","author":"A Aspelund","year":"2015","unstructured":"Aspelund, A. et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J. Exp. Med. 212, 991\u2013999 (2015).","journal-title":"J. Exp. Med."},{"key":"388_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","volume":"523","author":"A Louveau","year":"2015","unstructured":"Louveau, A. et al. Structural and functional features of central nervous system lymphatic vessels. Nature 523, 337\u2013341 (2015).","journal-title":"Nature"},{"key":"388_CR3","first-page":"1","volume":"7","author":"L Wang","year":"2017","unstructured":"Wang, L., Shao, C., Yang, C., Kang, X. & Zhang, G. Association of anti-gangliosides antibodies and anti-CMV antibodies in Guillain-Barr\u00e9 syndrome. Brain Behav. 7, 1\u20136 (2017).","journal-title":"Brain Behav."},{"key":"388_CR4","doi-asserted-by":"publisher","unstructured":"Fehmi, J., Scherer, S. S., Willison, H. J. & Rinaldi, S. Nodes, paranodes and neuropathies. J. Neurol. Neurosurg. Psychiatry 1\u201311 https:\/\/doi.org\/10.1136\/jnnp-2016-315480 (2017).","DOI":"10.1136\/jnnp-2016-315480"},{"key":"388_CR5","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/cbic.201600705","volume":"18","author":"S Groux-Degroote","year":"2017","unstructured":"Groux-Degroote, S., Gu\u00e9rardel, Y. & Delannoy, P. Gangliosides: structures, biosynthesis, analysis, and roles in cancer. ChemBioChem 18, 1146\u20131154 (2017).","journal-title":"ChemBioChem"},{"key":"388_CR6","doi-asserted-by":"publisher","first-page":"e0206881","DOI":"10.1371\/journal.pone.0206881","volume":"13","author":"Y Ohmi","year":"2018","unstructured":"Ohmi, Y. et al. Differential roles of gangliosides in malignant properties of melanomas. PLoS ONE 13, e0206881 (2018).","journal-title":"PLoS ONE"},{"key":"388_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jneuroim.2005.04.013","volume":"165","author":"AP Moran","year":"2005","unstructured":"Moran, A. P., Annuk, H. & Prendergast, M. M. Antibodies induced by ganglioside-mimicking Campylobacter jejuni lipooligosaccharides recognise epitopes at the nodes of Ranvier. J. Neuroimmunol. 165, 179\u2013185 (2005).","journal-title":"J. Neuroimmunol."},{"key":"388_CR8","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.patbio.2005.06.006","volume":"53","author":"V Sivadon","year":"2005","unstructured":"Sivadon, V. et al. Pr\u00e9valence et caract\u00e9ristiques des syndromes de Guillain-Barr\u00e9 associ\u00e9s \u00e0 Campylobacter jejuni et au cytom\u00e9galovirus en r\u00e9gion parisienne. Pathol. Biol. 53, 536\u2013538 (2005).","journal-title":"Pathol. Biol."},{"key":"388_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0000344","volume":"2","author":"CC Tam","year":"2007","unstructured":"Tam, C. C. et al. Guillain-Barr\u00e8 syndrome and preceding infection with Campylobacter, influenza and Epstein-Barr virus in the general practice research database. PLoS ONE 2, 1\u20136 (2007).","journal-title":"PLoS ONE"},{"key":"388_CR10","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1016\/j.jmb.2016.05.020","volume":"428","author":"RL Schnaar","year":"2016","unstructured":"Schnaar, R. L. Gangliosides of the vertebrate nervous system. J. Mol. Biol. 428, 3325\u20133336 (2016).","journal-title":"J. Mol. Biol."},{"key":"388_CR11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrm1103","volume":"4","author":"S Spiegel","year":"2003","unstructured":"Spiegel, S. & Milstien, S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 4, 397\u2013407 (2003).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"388_CR12","doi-asserted-by":"publisher","unstructured":"Spiegel, S. & Milstien, S. An enigmatic signalling lipid. https:\/\/doi.org\/10.1038\/nrm1103 (1884).","DOI":"10.1038\/nrm1103"},{"key":"388_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1172\/JCI0216127","volume":"110","author":"R Kolesnick","year":"2002","unstructured":"Kolesnick, R. Critical review: the therapeutic potential of modulating the ceramide\/sphingomyelin pathway. J. Clin. Invest. 110, 3\u20138 (2002).","journal-title":"J. Clin. Invest."},{"key":"388_CR14","unstructured":"Varki, A. & Schauer, R. Sialic Acids. Essentials of Glycobiology (Cold Spring Harbor Laboratory Press, 2009)."},{"key":"388_CR15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/175340a0","volume":"175","author":"G Blix","year":"1955","unstructured":"Blix, G., Lindberg, E., Odin, L. & Werner, I. Sialic acids. Nature 175, 340\u2013341 (1955).","journal-title":"Nature"},{"key":"388_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.molmed.2008.06.002","volume":"14","author":"A Varki","year":"2009","unstructured":"Varki, A. Sialic acids in human health and disease. Trends Mol. Med. 14, 351\u2013360 (2009).","journal-title":"Trends Mol. Med."},{"key":"388_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1152\/physrev.00033.2013","volume":"94","author":"RL Schnaar","year":"2014","unstructured":"Schnaar, R. L., Gerardy-Schahn, R. & Hildebrandt, H. Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration. Physiol. Rev. 94, 461\u2013518 (2014).","journal-title":"Physiol. Rev."},{"key":"388_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-018-0002-y","volume":"4","author":"F Krammer","year":"2018","unstructured":"Krammer, F. et al. Influenza. Nat. Rev. Dis. Prim. 4, 3 (2018).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"388_CR19","doi-asserted-by":"publisher","first-page":"170069","DOI":"10.1098\/rsob.170069","volume":"7","author":"ASB Olsen","year":"2017","unstructured":"Olsen, A. S. B. & F\u00e6rgeman, N. J. Sphingolipids: membrane microdomains in brain development, function and neurological diseases. Open Biol. 7, 170069 (2017).","journal-title":"Open Biol."},{"key":"388_CR20","doi-asserted-by":"publisher","first-page":"537","DOI":"10.5650\/jos.60.537","volume":"60","author":"RK Yu","year":"2011","unstructured":"Yu, R. K., Tsai, Y.-T., Ariga, T. & Yanagisawa, M. Structures, biosynthesis, and functions of gangliosides\u2013an overview. J. Oleo Sci. 60, 537\u2013544 (2011).","journal-title":"J. Oleo Sci."},{"key":"388_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-1-4684-7844-0_2","volume":"125","author":"L Svennerholm","year":"1980","unstructured":"Svennerholm, L. Ganglioside designation. Adv. Exp. Med. Biol. 125, 11 (1980).","journal-title":"Adv. Exp. Med. Biol."},{"key":"388_CR22","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/j.1471-4159.2010.07067.x","volume":"116","author":"Y Ohmi","year":"2011","unstructured":"Ohmi, Y. et al. Gangliosides are essential in the protection of inflammation and neurodegeneration via maintenance of lipid rafts: elucidation by a series of ganglioside-deficient mutant mice. J. Neurochem. 116, 926\u2013935 (2011).","journal-title":"J. Neurochem."},{"key":"388_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0166-4328(94)00131-X","volume":"66","author":"H Rahmann","year":"1995","unstructured":"Rahmann, H. Brain gangliosides and memory formation. Behav. Brain Res. 66, 105\u2013116 (1995).","journal-title":"Behav. Brain Res."},{"key":"388_CR24","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.3390\/nu7053891","volume":"7","author":"K Palmano","year":"2015","unstructured":"Palmano, K., Rowan, A., Guillermo, R., Guan, J. & McJarrow, P. The role of gangliosides in neurodevelopment. Nutrients 7, 3891\u20133913 (2015).","journal-title":"Nutrients"},{"key":"388_CR25","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1007\/s00018-005-5188-y","volume":"62","author":"I Mocchetti","year":"2005","unstructured":"Mocchetti, I. Exogenous gangliosides, neuronal plasticity and repair, and the neurotrophins. Cell. Mol. Life Sci. 62, 2283\u20132294 (2005).","journal-title":"Cell. Mol. Life Sci."},{"key":"388_CR26","doi-asserted-by":"publisher","unstructured":"Ceccarelli, B., Aporti, F. & Finesso, M. Effects of brain gangliosides on functional recovery in experimental regeneration and reinnervation. Ganglioside Funct. 275\u2013293 https:\/\/doi.org\/10.1007\/978-1-4614-4614-9_17 (1976).","DOI":"10.1007\/978-1-4614-4614-9_17"},{"key":"388_CR27","doi-asserted-by":"publisher","unstructured":"Ngamukote, S., Yanagisawa, M., Ariga, T., Ando, S. & Yu, R. K. Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains. J. NeuroChem. 2327\u20132341 https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04910.x (2007).","DOI":"10.1111\/j.1471-4159.2007.04910.x"},{"issue":"Suppl 2","key":"388_CR28","doi-asserted-by":"publisher","first-page":"S150","DOI":"10.1086\/513800","volume":"176","author":"N Yuki","year":"1997","unstructured":"Yuki, N. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barr\u00e9 syndrome and Miller Fisher syndrome. J. Infect. Dis. 176(Suppl 2), S150\u2013S153 (1997).","journal-title":"J. Infect. Dis."},{"key":"388_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0075720","volume":"8","author":"K Vajn","year":"2013","unstructured":"Vajn, K., Viljeti\u0107, B., Degme\u010di\u0107, I. V., Schnaar, R. L. & Heffer, M. Differential distribution of major brain gangliosides in the adult mouse central nervous system. PLoS ONE 8, 1\u201311 (2013).","journal-title":"PLoS ONE"},{"key":"388_CR30","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1083\/jcb.126.1.235","volume":"126","author":"T Kanda","year":"1994","unstructured":"Kanda, T., Yoshino, H., Ariga, T., Yamawaki, M. & Yu, R. K. Glycosphingolipid antigens in cultured microvascular bovine brain endothelial cells: Sulfoglucuronosyl paragloboside as a target of monoclonal IgM in demyelinative neuropathy. J. Cell Biol. 126, 235\u2013246 (1994).","journal-title":"J. Cell Biol."},{"key":"388_CR31","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/978-1-4939-1154-7_14","volume":"9","author":"K Furukawa","year":"2014","unstructured":"Furukawa, K., Ohmi, Y., Ohkawa, Y., Tajima, O. & Furukawa, K. Glycosphingolipids in the regulation of the nervous system. Adv. Neurobiol. 9, 307\u2013320 (2014).","journal-title":"Adv. Neurobiol."},{"key":"388_CR32","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1093\/glycob\/cwl052","volume":"17","author":"S Sonnino","year":"2007","unstructured":"Sonnino, S., Mauri, L., Chigorno, V. & Prinetti, A. Gangliosides as components of lipid membrane domains. Glycobiology 17, 1030 (2007). (vol 17, pg 1R-13R, 2007).","journal-title":"Glycobiology"},{"key":"388_CR33","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/42408","volume":"387","author":"K Simons","year":"1997","unstructured":"Simons, K. & Ikonen, E. Functional rafts in cell membranes. Nature 387, 569\u2013572 (1997).","journal-title":"Nature"},{"key":"388_CR34","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1194\/jlr.R200021-JLR200","volume":"44","author":"LJ Pike","year":"2003","unstructured":"Pike, L. J. Lipid rafts. J. Lipid Res. 44, 655\u2013667 (2003).","journal-title":"J. Lipid Res."},{"key":"388_CR35","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.5694\/j.1326-5377.2006.tb00705.x","volume":"185","author":"AW Hampson","year":"2006","unstructured":"Hampson, A. W. & Mackenzie, J. S. The influenza viruses. Med. J. Aust. 185, S39\u2013S43 (2006).","journal-title":"Med. J. Aust."},{"key":"388_CR36","doi-asserted-by":"publisher","unstructured":"Meri, S. Self-nonself discrimination by the complement system. FEBS Lett. 2418\u20132434 https:\/\/doi.org\/10.1002\/1873-3468.12284 (2016).","DOI":"10.1002\/1873-3468.12284"},{"key":"388_CR37","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1073\/pnas.87.10.3982","volume":"87","author":"S Meri","year":"1990","unstructured":"Meri, S. & Pangburn, M. K. Discrimination between activators and nonactivators of the alternative pathway of complement: Regulation via a sialic acid\/polyanion binding site on factor H. Proc. Natl Acad. Sci. USA 87, 3982\u20133986 (1990).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"388_CR38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nchembio.1696","volume":"11","author":"BS Blaum","year":"2015","unstructured":"Blaum, B. S. et al. Structural basis for sialic acid-mediated self-recognition by complement factor H. Nat. Chem. Biol. 11, 77\u201382 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"388_CR39","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1172\/JCI200420345","volume":"113","author":"EC Jury","year":"2004","unstructured":"Jury, E. C., Kabouridis, P. S., Flores-Borja, F., Mageed, R. A. & Isenberg, D. A. Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus. J. Clin. Invest. 113, 1176\u20131187 (2004).","journal-title":"J. Clin. Invest."},{"key":"388_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1006\/smim.2000.0204","volume":"12","author":"PW Janes","year":"2000","unstructured":"Janes, P. W., Ley, S. C., Magee, A. I. & Kabouridis, P. S. The role of lipid rafts in T cell antigen receptor (TCR) signalling. Semin. Immunol. 12, 23\u201334 (2000).","journal-title":"Semin. Immunol."},{"key":"388_CR41","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1126\/science.1719635","volume":"254","author":"I \u0160tefanov\u00e1","year":"1991","unstructured":"\u0160tefanov\u00e1, I., Ho\u0159ej\u0161\u00ed, V., Ansotegui, I. J., Knapp, W. & Stockinger, H. GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 254, 1016\u20131019 (1991).","journal-title":"Science"},{"key":"388_CR42","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1084\/jem.160.5.1558","volume":"160","author":"EM Medof","year":"1984","unstructured":"Medof, E. M., Kinoshita, T. & Nussenzweig, V. Inhibition of complement activation on the surface of cells after incorporation of Decay-Accelerating Factor (DAF) into their membranes. J. Exp. Med. 160, 1558\u20131578 (1984).","journal-title":"J. Exp. Med."},{"key":"388_CR43","first-page":"1","volume":"70","author":"S Meri","year":"1990","unstructured":"Meri, S. et al. Human protectin (CD59), an 18-20 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology 70, 1\u20139 (1990).","journal-title":"Immunology"},{"key":"388_CR44","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/0092-8674(93)90250-T","volume":"73","author":"J Takeda","year":"1993","unstructured":"Takeda, J. et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73, 703\u2013711 (1993).","journal-title":"Cell"},{"key":"388_CR45","first-page":"28","volume":"82","author":"A V\u00e4kev\u00e4","year":"1994","unstructured":"V\u00e4kev\u00e4, A., Jauhiainen, M., Ehnholm, C., Lehto, T. & Meri, S. High-density lipoproteins can act as carriers of glycophosphoinositol lipid-anchored CD59 in human plasma. Immunology 82, 28\u201333 (1994).","journal-title":"Immunology"},{"key":"388_CR46","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1053\/gast.2001.21197","volume":"120","author":"R Rautemaa","year":"2001","unstructured":"Rautemaa, R., Rautelin, H., Kokkola, A., K\u00e4rkk\u00e4inen, P. & Meri, S. Survival of Helicobacter pylori from complement lysis by binding of GPI-anchored protectin (CD59). Gastroenterology 120, 470\u2013479 (2001).","journal-title":"Gastroenterology"},{"key":"388_CR47","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/ng1460","volume":"36","author":"MA Simpson","year":"2004","unstructured":"Simpson, M. A. et al. Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat. Genet. 36, 1225\u20131229 (2004).","journal-title":"Nat. Genet."},{"key":"388_CR48","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/jnr.23411","volume":"92","author":"T Ariga","year":"2014","unstructured":"Ariga, T. Pathogenic role of ganglioside metabolism in neurodegenerative diseases. J. Neurosci. Res. 92, 1227\u20131242 (2014).","journal-title":"J. Neurosci. Res."},{"key":"388_CR49","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","volume":"388","author":"HJ Willison","year":"2016","unstructured":"Willison, H. J., Jacobs, B. C. & van Doorn, P. A. Guillain-Barr\u00e9 syndrome. Lancet 388, 717\u2013727 (2016).","journal-title":"Lancet"},{"key":"388_CR50","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0304-3940(88)90577-0","volume":"86","author":"J Chapman","year":"1988","unstructured":"Chapman, J., Sela, B. A., Wertman, E. & Michaelson, D. M. Antibodies to ganglioside GM1 in patients with Alzheimer\u2019s disease. Neurosci. Lett. 86, 235\u2013240 (1988).","journal-title":"Neurosci. Lett."},{"issue":"Suppl 3","key":"388_CR51","doi-asserted-by":"publisher","first-page":"S163","DOI":"10.3233\/JAD-132633","volume":"42","author":"E Koutsouraki","year":"2014","unstructured":"Koutsouraki, E. et al. The probable auto-antigenic role of lipids (anti-ganglioside antibodies) in the pathogenesis of Alzheimer\u2019s disease. J. Alzheimers Dis. 42(Suppl 3), S163\u2013S166 (2014).","journal-title":"J. Alzheimers Dis."},{"key":"388_CR52","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1177\/1533317514534953","volume":"29","author":"E Hatzifilippou","year":"2014","unstructured":"Hatzifilippou, E., Koutsouraki, E., Costa, V. G. & Baloyannis, S. J. Antibodies against gangliosides in patients with dementia. Am. J. Alzheimers Dis. Other Demen. 29, 660\u2013666 (2014).","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"key":"388_CR53","doi-asserted-by":"publisher","first-page":"e63326","DOI":"10.1371\/journal.pone.0063326","volume":"8","author":"T Ariga","year":"2013","unstructured":"Ariga, T. et al. Anti-Chol-1 antigen, GQ1b\u03b1, antibodies are associated with Alzheimer\u2019s disease. PLoS ONE 8, e63326 (2013).","journal-title":"PLoS ONE"},{"key":"388_CR54","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3233\/JAD-140474","volume":"42","author":"Y Miura","year":"2014","unstructured":"Miura, Y. et al. Autoantibodies to GM1 and GQ1b\u03b1 are not biological markers of Alzheimer\u2019s disease. J. Alzheimers Dis. 42, 1165\u20131169 (2014).","journal-title":"J. Alzheimers Dis."},{"key":"388_CR55","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10719-015-9579-5","volume":"32","author":"K Yanagisawa","year":"2015","unstructured":"Yanagisawa, K. GM1 ganglioside and Alzheimer\u2019s disease. Glycoconj. J. 32, 87\u201391 (2015).","journal-title":"Glycoconj. J."},{"key":"388_CR56","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1034\/j.1600-0404.2002.01240.x","volume":"106","author":"M Zappia","year":"2002","unstructured":"Zappia, M. et al. Anti-GM1 ganglioside antibodies in Parkinson\u2019s disease. Acta Neurol. Scand. 106, 54\u201357 (2002).","journal-title":"Acta Neurol. Scand."},{"key":"388_CR57","doi-asserted-by":"crossref","unstructured":"Schneider, J. S. GM1 ganglioside in the treatment of Parkinson\u2019s disease. Ann. N.Y. Acad. Sci. 845, 363\u2013373 (1998).","DOI":"10.1111\/j.1749-6632.1998.tb09688.x"},{"key":"388_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0125339","volume":"10","author":"K Kollewe","year":"2015","unstructured":"Kollewe, K. et al. Anti-ganglioside antibodies in amyotrophic lateral sclerosis revisited. PLoS ONE 10, 1\u201311 (2015).","journal-title":"PLoS ONE"},{"key":"388_CR59","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1085-9489.2004.09207.x","volume":"9","author":"V Scaioli","year":"2004","unstructured":"Scaioli, V., Andreetta, F. & Mantegazza, R. Unusual neurophysiological and immunological findings in myasthenia gravis: a case report. J. Peripher. Nerv. Syst. 9, 92\u201397 (2004).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"388_CR60","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/(SICI)1097-4598(199910)22:10<1461::AID-MUS19>3.0.CO;2-T","volume":"22","author":"Y Mitsui","year":"1999","unstructured":"Mitsui, Y. et al. Sensorimotor polyneuropathy associated with chronic lymphocytic leukemia, IgM antigangliosides antibody and human T-cell leukemia virus I infection. Muscle Nerve 22, 1461\u20131465 (1999).","journal-title":"Muscle Nerve"},{"key":"388_CR61","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jns.2018.03.030","volume":"388","author":"V Favoni","year":"2018","unstructured":"Favoni, V., Liguori, R., Incensi, A., Fileccia, E. & Donadio, V. The incidental finding of elevated anti GQ1B antibodies in a patient with selective small fiber neuropathy. J. Neurol. Sci. 388, 192\u2013194 (2018).","journal-title":"J. Neurol. Sci."},{"key":"388_CR62","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/ana.410440621","volume":"44","author":"BT Sadatipour","year":"1998","unstructured":"Sadatipour, B. T., Greer, J. M. & Pender, M. P. Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis. Ann. Neurol. 44, 980\u2013983 (1998).","journal-title":"Ann. Neurol."},{"key":"388_CR63","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/1531-8249(200005)47:5<684::AID-ANA27>3.0.CO;2-O","volume":"47","author":"G Giovannoni","year":"2000","unstructured":"Giovannoni, G., Morris, P. R. & Keir, G. Circulating antiganglioside antibodies are not associated with the development of progressive disease or cerebral atrophy in patients with multiple sclerosis. Ann. Neurol. 47, 684\u2013685 (2000).","journal-title":"Ann. Neurol."},{"key":"388_CR64","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1177\/1352458508096685","volume":"15","author":"P Valentino","year":"2009","unstructured":"Valentino, P. et al. Anti-GM1 antibodies are not associated with cerebral atrophy in patients with multiple sclerosis. Mult. Scler. J. 15, 114\u2013115 (2009).","journal-title":"Mult. Scler. J."},{"key":"388_CR65","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0967-5868(02)00270-9","volume":"10","author":"MP Pender","year":"2003","unstructured":"Pender, M. P. et al. Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis. J. Clin. Neurosci. 10, 63\u201366 (2003).","journal-title":"J. Clin. Neurosci."},{"key":"388_CR66","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/BF02030510","volume":"9","author":"LT Costallat","year":"1990","unstructured":"Costallat, L. T., de Oliveira, R. M., Santiago, M. B., Cossermelli, W. & Samara, A. M. Neuropsychiatric manifestations of systemic lupus erythematosus: the value of anticardiolipin, antigangliosides and antigalactocerebrosides antibodies. Clin. Rheumatol. 9, 489\u2013497 (1990).","journal-title":"Clin. Rheumatol."},{"key":"388_CR67","first-page":"135","volume":"27","author":"M Galeazzi","year":"2000","unstructured":"Galeazzi, M. et al. Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: clinical, serological, and HLA class II gene associations. European Concerted Action on the Immunogenetics of SLE. J. Rheumatol. 27, 135\u2013141 (2000).","journal-title":"J. Rheumatol."},{"key":"388_CR68","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1590\/S0004-282X2004000600007","volume":"62","author":"JI Siqueira Neto","year":"2004","unstructured":"Siqueira Neto, J. I., Leite Vieira Costa, A. C., Magalh\u00e3es, F. G. & Sampaio Silva, G. Neurological manifestations of celiac disease. Arq. Neuropsiquiatr. 62, 969\u2013972 (2004).","journal-title":"Arq. Neuropsiquiatr."},{"key":"388_CR69","doi-asserted-by":"publisher","first-page":"S92","DOI":"10.1053\/j.gastro.2005.02.018","volume":"128","author":"KO Bushara","year":"2005","unstructured":"Bushara, K. O. Neurologic presentation of celiac disease. Gastroenterology 128, S92\u2013S97 (2005).","journal-title":"Gastroenterology"},{"key":"388_CR70","first-page":"763","volume":"126","author":"M Przybylska-Felu\u015b","year":"2016","unstructured":"Przybylska-Felu\u015b, M. et al. Anti-GM1 ganglioside antibodies, neuron specific enolase and interleukin 10 concentrations as potential markers of autonomic nervous system impairment in celiac disease - preliminary findings. Pol. Arch. Intern. Med. 126, 763\u2013771 (2016).","journal-title":"Pol. Arch. Intern. Med."},{"key":"388_CR71","doi-asserted-by":"publisher","first-page":"4784","DOI":"10.3748\/wjg.v13.i35.4784","volume":"13","author":"B Sabayan","year":"2007","unstructured":"Sabayan, B., Foroughinia, F. & Imanieh, M.-H. Can Campylobacter jejuni play a role in development of celiac disease? A hypothesis. World J. Gastroenterol. 13, 4784\u20134785 (2007).","journal-title":"World J. Gastroenterol."},{"key":"388_CR72","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jneuroim.2006.04.022","volume":"177","author":"A Alaedini","year":"2006","unstructured":"Alaedini, A. & Latov, N. Transglutaminase-independent binding of gliadin to intestinal brush border membrane and GM1 ganglioside. J. Neuroimmunol. 177, 167\u2013172 (2006).","journal-title":"J. Neuroimmunol."},{"key":"388_CR73","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/mus.21326","volume":"41","author":"M Lucchetta","year":"2010","unstructured":"Lucchetta, M. et al. Anti-ganglioside autoantibodies in type 1 diabetes. Muscle Nerve 41, 50\u201353 (2010).","journal-title":"Muscle Nerve"},{"key":"388_CR74","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.diabres.2016.02.005","volume":"115","author":"S Ge","year":"2016","unstructured":"Ge, S. et al. Associations of serum anti-ganglioside autoantibodies and inflammatory markers in diabetetic peripheral neuropathy. Diabetes Res Clin. Pr. 115, 68\u201376 (2016).","journal-title":"Diabetes Res Clin. Pr."},{"key":"388_CR75","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1196\/annals.1398.031","volume":"1109","author":"K Conrad","year":"2007","unstructured":"Conrad, K. et al. A new line immunoassay for the multiparametric detection of antiganglioside autoantibodies in patients with autoimmune peripheral neuropathies. Ann. N.Y. Acad. Sci. 1109, 256\u2013264 (2007).","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"388_CR76","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jocn.2013.07.041","volume":"21","author":"W Johannis","year":"2014","unstructured":"Johannis, W., Renno, J. H., Klatt, A. R. & Wielckens, K. Anti-glycolipid antibodies in patients with neuropathy: a diagnostic assessment. J. Clin. Neurosci. 21, 488\u2013492 (2014).","journal-title":"J. Clin. Neurosci."},{"key":"388_CR77","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jneuroim.2005.11.017","volume":"173","author":"RD Lardone","year":"2006","unstructured":"Lardone, R. D., Alaniz, M. E., Irazoqui, F. J. & Nores, G. A. Unusual presence of anti-GM1 IgG-antibodies in a healthy individual, and their possible involvement in the origin of disease-associated anti-GM1 antibodies. J. Neuroimmunol. 173, 174\u2013179 (2006).","journal-title":"J. Neuroimmunol."},{"key":"388_CR78","unstructured":"Guillain, G., Barr\u00e9, J. A. & Strohl, A. [Sur un syndrome de radiculo-n\u00e9vrite avec hyperalbuminose du liquide c\u00e9phalo-rachidien sans r\u00e9action cellulaire. Remarques sur les caract\u00e8res cliniques et graphiques des r\u00e9flexes tendineux]. Ann. Med. Interne 40, 1462\u20131470 (1916)."},{"key":"388_CR79","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrneurol.2016.172","volume":"12","author":"JA Goodfellow","year":"2016","unstructured":"Goodfellow, J. A. & Willison, H. J. Guillain-Barr\u00e9 syndrome: a century of progress. Nat. Rev. Neurol. 12, 723\u2013731 (2016).","journal-title":"Nat. Rev. Neurol."},{"key":"388_CR80","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1007\/s00415-015-7806-4","volume":"262","author":"M Koga","year":"2015","unstructured":"Koga, M., Takahashi, M., Yokoyama, K. & Kanda, T. Ambiguous value of anti-ganglioside IgM autoantibodies in Guillain-Barr\u00e9 syndrome and its variants. J. Neurol. 262, 1954\u20131960 (2015).","journal-title":"J. Neurol."},{"key":"388_CR81","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/B978-0-444-52902-2.00021-7","volume":"115","author":"H Fujimura","year":"2013","unstructured":"Fujimura, H. The Guillain-Barr\u00e9 syndrome. Handb. Clin. Neurol. 115, 383\u2013402 (2013).","journal-title":"Handb. Clin. Neurol."},{"key":"388_CR82","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrneurol.2014.138","volume":"10","author":"BR Wakerley","year":"2014","unstructured":"Wakerley, B. R. et al. Guillain\u2013Barr\u00e9 and Miller Fisher syndromes\u2014new diagnostic classification. Nat. Rev. Neurol. 10, 537\u2013544 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"388_CR83","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jocn.2008.08.033","volume":"16","author":"S Vucic","year":"2009","unstructured":"Vucic, S., Kiernan, M. C. & Cornblath, D. R. Guillain-Barr\u00e9 syndrome: an update. J. Clin. Neurosci. 16, 733\u2013741 (2009).","journal-title":"J. Clin. Neurosci."},{"key":"388_CR84","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1093\/brain\/aww189","volume":"139","author":"K Doppler","year":"2016","unstructured":"Doppler, K. et al. Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy. Brain 139, 2617\u20132630 (2016).","journal-title":"Brain"},{"key":"388_CR85","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.4103\/neuroindia.NI_1226_15","volume":"65","author":"Gs Naik","year":"2017","unstructured":"Naik, Gs et al. Anti-ganglioside antibodies profile in guillain-barr\u00e9 syndrome: correlation with clinical features, electrophysiological pattern, and outcome. Neurol. India 65, 1001 (2017).","journal-title":"Neurol. India"},{"key":"388_CR86","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/S1474-4422(13)70215-1","volume":"12","author":"S Kuwabara","year":"2013","unstructured":"Kuwabara, S. & Yuki, N. Axonal Guillain-Barr\u00e9 syndrome: concepts and controversies. Lancet Neurol. 12, 1180\u20131188 (2013).","journal-title":"Lancet Neurol."},{"key":"388_CR87","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1136\/jnnp-2014-310097","volume":"86","author":"A Uncini","year":"2015","unstructured":"Uncini, A. & Kuwabara, S. Nodopathies of the peripheral nerve: an emerging concept. J. Neurol. Neurosurg. Psychiatry 86, 1186\u20131195 (2015).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"388_CR88","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","volume":"366","author":"RA Hughes","year":"2005","unstructured":"Hughes, R. A. & Cornblath, D. R. Guillain-Barr\u00e9 syndrome. Lancet 366, 1653\u20131666 (2005).","journal-title":"Lancet"},{"key":"388_CR89","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2183\/pjab.88.299","volume":"88","author":"N Yuki","year":"2012","unstructured":"Yuki, N. Guillain-Barr\u00e9 syndrome and anti-ganglioside antibodies: a clinician-scientist\u2019s journey. Proc. Jpn. Acad. Ser. B. Phys. Biol. Sci. 88, 299\u2013326 (2012).","journal-title":"Proc. Jpn. Acad. Ser. B. Phys. Biol. Sci."},{"key":"388_CR90","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1056\/NEJM195607122550201","volume":"255","author":"M Fisher","year":"1956","unstructured":"Fisher, M. An unusual variant of acute idiopathic polyneuritis (syndrome of sphthalmoplegia, Ataxia and areflexia). N. Engl. J. Med. 255, 57\u201365 (1956).","journal-title":"N. Engl. J. Med."},{"key":"388_CR91","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1136\/jnnp-2012-302824","volume":"84","author":"N Shahrizaila","year":"2013","unstructured":"Shahrizaila, N. & Yuki, N. Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome. J. Neurol. Neurosurg. Psychiatry 84, 576\u2013583 (2013).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"388_CR92","first-page":"1371","volume":"67","author":"S Kuwabara","year":"2015","unstructured":"Kuwabara, S. Fisher syndrome and Bickerstaff brainstem encephalitis. Brain Nerve 67, 1371\u20131376 (2015).","journal-title":"Brain Nerve"},{"key":"388_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0022-510X(01)00465-8","volume":"185","author":"HJ Willison","year":"2001","unstructured":"Willison, H. J. Fine specificity of anti-GQ1b antibodies and clinical features. J. Neurol. Sci. 185, 1\u20132 (2001).","journal-title":"J. Neurol. Sci."},{"key":"388_CR94","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1128\/IAI.66.8.3649-3655.1998","volume":"66","author":"MM Prendergast","year":"1998","unstructured":"Prendergast, M. M., Lastovica, A. J. & Moran, A. P. Lipopolysaccharides from Campylobacter jejuni O: 41 Strains associated with Guillain-Barre syndrome exhibit mimicry of GM1 ganglioside. Infect. Immun. 66, 3649\u20133655 (1998).","journal-title":"Infect. Immun."},{"key":"388_CR95","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1086\/314462","volume":"178","author":"AP Moran","year":"1998","unstructured":"Moran, A. P. & Prendergast, M. M. Molecular mimicry in Campylobacter jejuni lipopolysaccharides and the development of Guillain-Barr\u00e9 syndrome. J. Infect. Dis. 178, 1549\u20131551 (1998).","journal-title":"J. Infect. Dis."},{"key":"388_CR96","first-page":"10","volume":"2011","author":"N Yuki","year":"2011","unstructured":"Yuki, N. & Shahrizaila, N. Guillain-Barr\u00e9 syndrome animal model: the first proof of molecular mimicry in human autoimmune disorder. J. Biomed. Biotechnol. 2011, 10\u201314 (2011).","journal-title":"J. Biomed. Biotechnol."},{"key":"388_CR97","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3329\/jhpn.v28i6.6602","volume":"28","author":"KO Poropatich","year":"2010","unstructured":"Poropatich, K. O., Walker, C. L. F. & Black, R. E. Quantifying the association between Campylobacter infection and Guillain-Barr\u00e9 syndrome: a systematic review. J. Health Popul. Nutr. 28, 545\u2013552 (2010).","journal-title":"J. Health Popul. Nutr."},{"key":"388_CR98","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3201\/eid0402.980213","volume":"4","author":"BM Allos","year":"1998","unstructured":"Allos, B. M., Lippy, F. T., Carlsen, A., Washburn, R. G. & Blaser, M. J. Campylobacter jejuni strains from patients with Guillain-Barre syndrome. Emerg. Infect. Dis. 4, 263\u2013268 (1998).","journal-title":"Emerg. Infect. Dis."},{"key":"388_CR99","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/ana.1012","volume":"49","author":"N Yuki","year":"2001","unstructured":"Yuki, N. et al. Animal model of axonal Guillain-Barr\u00e9 syndrome induced by sensitization with GM1 ganglioside. Ann. Neurol. 49, 712\u2013720 (2001).","journal-title":"Ann. Neurol."},{"key":"388_CR100","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jneuroim.2008.09.016","volume":"205","author":"V Phongsisay","year":"2008","unstructured":"Phongsisay, V. et al. Complement inhibitor prevents disruption of sodium channel clusters in a rabbit model of Guillain-Barr\u00e9 syndrome. J. Neuroimmunol. 205, 101\u2013104 (2008).","journal-title":"J. Neuroimmunol."},{"key":"388_CR101","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","volume":"51","author":"BC Jacobs","year":"1998","unstructured":"Jacobs, B. C. et al. The spectrum of antecedent infections in Guillain-Barr\u00e9 syndrome: a case-control study. Neurology 51, 1110\u20131115 (1998).","journal-title":"Neurology"},{"key":"388_CR102","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3345\/kjp.2014.57.10.457","volume":"57","author":"YIl Rho","year":"2014","unstructured":"Rho, Y. Il Overlapping Guillain-Barr\u00e9 syndrome and Bickerstaff\u2019s brainstem encephalitis associated with Epstein Barr virus. Korean J. Pediatr. 57, 457 (2014).","journal-title":"Korean J. Pediatr."},{"key":"388_CR103","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/cmi.2017.142","volume":"15","author":"Y Rodr\u00edguez","year":"2018","unstructured":"Rodr\u00edguez, Y. et al. Guillain\u2013Barr\u00e9 syndrome, transverse myelitis and infectious diseases. Cell. Mol. Immunol. 15, 547\u2013562 (2018).","journal-title":"Cell. Mol. Immunol."},{"key":"388_CR104","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1016\/S0163-4453(17)30198-6","volume":"74","author":"RCA de Groot","year":"2017","unstructured":"de Groot, R. C. A., Meyer Sauteur, P. M., Unger, W. W. J. & van Rossum, A. M. C. Things that could be Mycoplasma pneumoniae. J. Infect. 74, S95\u2013S100 (2017).","journal-title":"J. Infect."},{"key":"388_CR105","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/jns.12121","volume":"20","author":"PM Meyer Sauteur","year":"2015","unstructured":"Meyer Sauteur, P. M. et al. Severe childhood Guillain-Barr\u00e9 syndrome associated with Mycoplasma pneumoniae infection: a case series. J. Peripher. Nerv. Syst. 20, 72\u201378 (2015).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"388_CR106","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/ana.24755","volume":"80","author":"PM Meyer Sauteur","year":"2016","unstructured":"Meyer Sauteur, P. M. et al. Mycoplasma pneumoniae triggering the Guillain-Barr\u00e9 syndrome: a case-control study. Ann. Neurol. 80, 566\u2013580 (2016).","journal-title":"Ann. Neurol."},{"key":"388_CR107","first-page":"372","volume":"51","author":"S Nafissi","year":"2013","unstructured":"Nafissi, S., Vahabi, Z., Sadeghi Ghahar, M., Amirzargar, A. A. & Naderi, S. The role of cytomegalovirus, Haemophilus influenzae and Epstein Barr virus in Guillain Barre syndrome. Acta Med. Iran. 51, 372\u2013376 (2013).","journal-title":"Acta Med. Iran."},{"key":"388_CR108","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1093\/brain\/123.10.2171","volume":"123","author":"M Mori","year":"2000","unstructured":"Mori, M. et al. Haemophilus influenzae infection and Guillain-Barr\u00e9 syndrome. Brain 123, 2171\u20132178 (2000).","journal-title":"Brain"},{"key":"388_CR109","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1212\/WNL.52.6.1282","volume":"52","author":"M Mori","year":"1999","unstructured":"Mori, M. et al. Haemophilus influenzae has a GM1 ganglioside-like structure and elicits Guillain-Barr\u00e9 syndrome. Neurology 52, 1282\u20131284 (1999).","journal-title":"Neurology"},{"key":"388_CR110","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1212\/01.WNL.0000160399.08456.7C","volume":"64","author":"M Koga","year":"2005","unstructured":"Koga, M. et al. Antecedent infections in Fisher syndrome: A common pathogenesis of molecular mimicry. Neurology 64, 1605\u20131611 (2005).","journal-title":"Neurology"},{"key":"388_CR111","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1136\/jnnp.62.6.641","volume":"62","author":"BC Jacobs","year":"1997","unstructured":"Jacobs, B. C., van Doorn, P. A., Groeneveld, J. H., Tio-Gillen, A. P. & van der Mech\u00e9, F. G. Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barr\u00e9 syndrome. J. Neurol. Neurosurg. Psychiatry 62, 641\u2013643 (1997).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"388_CR112","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0165-5728(96)00059-8","volume":"68","author":"S Irie","year":"1996","unstructured":"Irie, S. et al. Association of anti-GM2 antibodies in Guillain-Barr\u00e9 syndrome with acute cytomegalovirus infection. J. Neuroimmunol. 68, 19\u201326 (1996).","journal-title":"J. Neuroimmunol."},{"key":"388_CR113","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.jpeds.2014.06.014","volume":"165","author":"M Science","year":"2014","unstructured":"Science, M. et al. Central nervous system complications of Varicella-Zoster virus. J. Pediatr. 165, 779\u2013785 (2014).","journal-title":"J. Pediatr."},{"key":"388_CR114","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3109\/00207454.2015.1033621","volume":"126","author":"P Tatarelli","year":"2016","unstructured":"Tatarelli, P. et al. Guillain-Barr\u00e9 syndrome following chickenpox: A case series. Int. J. Neurosci. 126, 478\u2013479 (2016).","journal-title":"Int. J. Neurosci."},{"key":"388_CR115","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.15585\/mmwr.mm6649a2","volume":"66","author":"A Satterfield-Nash","year":"2017","unstructured":"Satterfield-Nash, A. et al. Health and development at age 19\u201324 months of 19 children who were born with microcephaly and laboratory evidence of congenital Zika virus infection during the 2015 Zika virus outbreak\u2014Brazil, 2017. Mmwr. Morb. Mortal. Wkly. Rep. 66, 1347\u20131351 (2017).","journal-title":"Mmwr. Morb. Mortal. Wkly. Rep."},{"key":"388_CR116","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","volume":"387","author":"VM Cao-Lormeau","year":"2016","unstructured":"Cao-Lormeau, V. M. et al. Guillain-Barr\u00e9 Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387, 1531\u20131539 (2016).","journal-title":"Lancet"},{"key":"388_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-016-0601-y","volume":"14","author":"JM Anaya","year":"2016","unstructured":"Anaya, J. M. et al. Zika virus and neurologic autoimmunity: the putative role of gangliosides. BMC Med. 14, 1\u20133 (2016).","journal-title":"BMC Med."},{"key":"388_CR118","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.autrev.2016.03.020","volume":"15","author":"G Lucchese","year":"2016","unstructured":"Lucchese, G. & Kanduc, D. Zika virus and autoimmunity: from microcephaly to Guillain-Barr\u00e9 syndrome, and beyond. Autoimmun. Rev. 15, 801\u2013808 (2016).","journal-title":"Autoimmun. Rev."},{"key":"388_CR119","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fmed.2018.00025","volume":"5","author":"D Nico","year":"2018","unstructured":"Nico, D. et al. Prevalence of IgG autoantibodies against GD3 Ganglioside in acute Zika virus infection. Front. Med. 5, 25 (2018).","journal-title":"Front. Med."},{"key":"388_CR120","doi-asserted-by":"crossref","unstructured":"Baskar, D., Amalnath, D., Mandal, J., Dhodapkar, R. & Vanathi, K. Antibodies to Zika virus, Campylobacter jejuni and gangliosides in Guillain-Barre syndrome: a prospective single-center study from southern India. Neurol. India 66, 1324\u20131331","DOI":"10.4103\/0028-3886.241402"},{"key":"388_CR121","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1001\/jamaneurol.2016.3541","volume":"74","author":"O Stevens","year":"2017","unstructured":"Stevens, O., Claeys, K. G., Poesen, K., Saegeman, V. & Van Damme, P. Diagnostic challenges and clinical characteristics of hepatitis e virus-associated guillain-Barr\u00e9 syndrome. JAMA Neurol. 74, 26\u201333 (2017).","journal-title":"JAMA Neurol."},{"key":"388_CR122","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.carres.2016.08.004","volume":"434","author":"K Miyaji","year":"2016","unstructured":"Miyaji, K. et al. Altered gene expression of glycosyltransferases and sialyltransferases and total amount of glycosphingolipids following herpes simplex virus infection. Carbohydr. Res. 434, 37\u201343 (2016).","journal-title":"Carbohydr. Res."},{"key":"388_CR123","doi-asserted-by":"publisher","unstructured":"Sequeira, J., Calado, A., Dias, M. & Manita, M. Parvovirus B19 infection associated with hemolytic anemia and cranial polyneuropathy. J. Neurovirol. https:\/\/doi.org\/10.1007\/s13365-017-0562-8 (2017).","DOI":"10.1007\/s13365-017-0562-8"},{"key":"388_CR124","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1113\/jphysiol.2009.171702","volume":"587","author":"JJ Plomp","year":"2009","unstructured":"Plomp, J. J. & Willison, H. J. Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction. J. Physiol. 587, 3979\u20133999 (2009).","journal-title":"J. Physiol."},{"key":"388_CR125","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1093\/brain\/124.5.893","volume":"124","author":"GM O\u2019Hanlon","year":"2001","unstructured":"O\u2019Hanlon, G. M. et al. Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal. Brain 124, 893\u2013906 (2001).","journal-title":"Brain"},{"key":"388_CR126","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1212\/WNL.55.4.585","volume":"55","author":"T Kanda","year":"2000","unstructured":"Kanda, T., Iwasaki, T., Yamawaki, M., Tai, T. & Mizusawa, H. Anti-GM1 antibody facilitates leakage in an in vitro blood-nerve barrier model. Neurology 55, 585\u2013587 (2000).","journal-title":"Neurology"},{"key":"388_CR127","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3727\/000000007783464731","volume":"16","author":"BS Desai","year":"2007","unstructured":"Desai, B. S., Monahan, A. J., Carvey, P. M. & Hendey, B. Blood-brain barrier pathology in Alzheimer\u2019s and Parkinson\u2019s disease: implications for drug therapy. Cell Transplant. 16, 285\u2013299 (2007).","journal-title":"Cell Transplant."},{"key":"388_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.00442","volume":"8","author":"MP Platt","year":"2017","unstructured":"Platt, M. P., Agalliu, D. & Cutforth, T. Hello from the other side: how autoantibodies circumvent the blood-brain barrier in autoimmune encephalitis. Front. Immunol. 8, 1\u201315 (2017).","journal-title":"Front. Immunol."},{"key":"388_CR129","doi-asserted-by":"publisher","unstructured":"Lee, J., Na, G., Joo, E. Y., Lee, M. & Lee, J. Clinical and polysomnographic characteristics of excessive daytime sleepiness in children. Sleep Breath. https:\/\/doi.org\/10.1007\/s11325-017-1545-y (2017).","DOI":"10.1007\/s11325-017-1545-y"},{"key":"388_CR130","doi-asserted-by":"publisher","unstructured":"Postiglione, E. et al. The clinical spectrum of childhood narcolepsy. Sleep Med. Rev. https:\/\/doi.org\/10.1016\/j.smrv.2017.04.003 (2017).","DOI":"10.1016\/j.smrv.2017.04.003"},{"key":"388_CR131","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S1474-4422(14)70075-4","volume":"13","author":"M Partinen","year":"2014","unstructured":"Partinen, M. et al. Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. Lancet Neurol. 13, 600\u2013613 (2014).","journal-title":"Lancet Neurol."},{"key":"388_CR132","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S1389-9457(00)00081-2","volume":"2","author":"M Thorpy","year":"2001","unstructured":"Thorpy, M. Current concepts in the etiology, diagnosis and treatment of narcolepsy. Sleep. Med. 2, 5\u201317 (2001).","journal-title":"Sleep. Med."},{"key":"388_CR133","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0092-8674(00)81965-0","volume":"98","author":"L Lin","year":"1999","unstructured":"Lin, L. et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98, 365\u2013376 (1999).","journal-title":"Cell"},{"key":"388_CR134","first-page":"1012","volume":"20","author":"E Mignot","year":"1997","unstructured":"Mignot, E., Hayduk, R., Black, J., Grumet, F. C. & Guilleminault, C. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 20, 1012\u20131020 (1997).","journal-title":"Sleep"},{"key":"388_CR135","doi-asserted-by":"publisher","first-page":"10956","DOI":"10.1073\/pnas.1603325113","volume":"113","author":"R Bernard-Valnet","year":"2016","unstructured":"Bernard-Valnet, R. et al. CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice. Proc. Natl Acad. Sci. USA 113, 10956\u201310961 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"388_CR136","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033536","volume":"7","author":"H Nohynek","year":"2012","unstructured":"Nohynek, H. et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS ONE 7, e33536. https:\/\/doi.org\/10.1371\/journal.pone.0033536\u00a0(2012).","journal-title":"PLoS ONE"},{"key":"388_CR137","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jaut.2015.07.006","volume":"63","author":"AH Saariaho","year":"2015","unstructured":"Saariaho, A. H. et al. Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus. J. Autoimmun. 63, 68\u201375 (2015).","journal-title":"J. Autoimmun."},{"key":"388_CR138","doi-asserted-by":"publisher","first-page":"B6","DOI":"10.1016\/j.vaccine.2015.03.026","volume":"33","author":"MCJM Sturkenboom","year":"2015","unstructured":"Sturkenboom, M. C. J. M. The narcolepsy-pandemic influenza story: can the truth ever be unraveled? Vaccine 33, B6\u2013B13 (2015).","journal-title":"Vaccine"},{"key":"388_CR139","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/ana.22587","volume":"70","author":"F Han","year":"2011","unstructured":"Han, F. et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in china. Ann. Neurol. 70, 410\u2013417 (2011).","journal-title":"Ann. Neurol."},{"key":"388_CR140","doi-asserted-by":"publisher","first-page":"E12323","DOI":"10.1073\/pnas.1818150116","volume":"115","author":"G Luo","year":"2018","unstructured":"Luo, G. et al. Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy. Proc. Natl Acad. Sci. USA 115, E12323\u2013E12332 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"388_CR141","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1016\/j.vaccine.2014.03.085","volume":"32","author":"S Masoudi","year":"2014","unstructured":"Masoudi, S., Ploen, D., Kunz, K. & Hildt, E. The adjuvant component \u03b1-tocopherol triggers via modulation of Nrf2 the expression and turnover of hypocretin in vitro and its implication to the development of narcolepsy. Vaccine 32, 2980\u20132988 (2014).","journal-title":"Vaccine"},{"key":"388_CR142","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.1016\/j.vaccine.2015.07.055","volume":"33","author":"WJ Kim","year":"2015","unstructured":"Kim, W. J. et al. Incidence of narcolepsy before and after MF59-adjuvanted influenza A(H1N1)pdm09 vaccination in South Korean soldiers. Vaccine 33, 4868\u20134872 (2015).","journal-title":"Vaccine"},{"key":"388_CR143","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1080\/21645515.2016.1168954","volume":"12","author":"Q Canelle","year":"2016","unstructured":"Canelle, Q., Innis, B. L. & Most, R. VanDer. Evaluation of potential immunogenicity differences between Pandemrix\u2122 and Arepanrix\u2122. Human Vaccines Immunotherapeut. 12, 2289\u20132298 (2016).","journal-title":"Human Vaccines Immunotherapeut."},{"key":"388_CR144","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bbi.2014.11.004","volume":"47","author":"L Jacob","year":"2015","unstructured":"Jacob, L. et al. Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development. Brain. Behav. Immun. 47, 44\u201357 (2015).","journal-title":"Brain. Behav. Immun."},{"key":"388_CR145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0114361","volume":"9","author":"O Vaarala","year":"2014","unstructured":"Vaarala, O. et al. Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: Implications for pandemrix-associated narcolepsy risk. PLoS ONE 9, 1\u201323 (2014).","journal-title":"PLoS ONE"},{"key":"388_CR146","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/978-1-61779-166-6_17","volume":"757","author":"T Kinashi","year":"2011","unstructured":"Kinashi, T. Overview of integrin signaling in the immune system. Methods Mol. Biol. 757, 261\u2013278 (2011).","journal-title":"Methods Mol. Biol."},{"key":"388_CR147","doi-asserted-by":"publisher","first-page":"27213","DOI":"10.1074\/jbc.M109.087791","volume":"285","author":"Y Ohkawa","year":"2010","unstructured":"Ohkawa, Y. et al. Ganglioside GD3 enhances adhesion signals and augments malignant properties of melanoma cells by recruiting integrins to glycolipid-enriched microdomains. J. Biol. Chem. 285, 27213\u201327223 (2010).","journal-title":"J. Biol. Chem."},{"key":"388_CR148","doi-asserted-by":"publisher","first-page":"537","DOI":"10.5650\/jos.60.537","volume":"60","author":"RK Yu","year":"2011","unstructured":"Yu, R. K., Tsai, Y. T., Ariga, T. & Yanagisawa, M. Structures, biosynthesis, and functions of gangliosides-an overview. J. Oleo Sci. 60, 537\u2013544 (2011).","journal-title":"J. Oleo Sci."},{"key":"388_CR149","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jneuroim.2006.04.022","volume":"177","author":"A Alaedini","year":"2006","unstructured":"Alaedini, A. & Latov, N. Transglutaminase-independent binding of gliadin ton intestinal brush border membrane and GM1 ganglioside. J. Neuroimmunol. 177, 167\u2013172 (2006).","journal-title":"J. Neuroimmunol."},{"key":"388_CR150","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1073\/pnas.012540899","volume":"99","author":"S Hakomori","year":"2002","unstructured":"Hakomori, S. The glycosynapse. Proc. Natl Acad. Sci. USA 99, 225\u2013232 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"388_CR151","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1242\/dmm.027870","volume":"10","author":"U Rodella","year":"2017","unstructured":"Rodella, U. et al. Schwann cells are activated by ATP released from neurons in an in vitro cellular model of Miller Fisher syndrome. Dis. Model. Mech. 10, 597\u2013603 (2017).","journal-title":"Dis. Model. Mech."},{"key":"388_CR152","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/BF02030510","volume":"9","author":"LT Costallat","year":"1990","unstructured":"Costallat, L. T., de Oliveira, R. M., Santiago, M. B., CossermelliW & Samara, A. M. Neuropsychiatric manifestations of systemic lupus erythematosus: the value of anticardiolipi, antigangliosides, anticerebrosides antibodies. Clin. Rheumatol. 9, 489\u2013497 (1990).","journal-title":"Clin. Rheumatol."},{"issue":"Suppl 4","key":"388_CR153","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-S4-P25","volume":"14","author":"I Nicolae","year":"2014","unstructured":"Nicolae, I., Nicolae, C. D. E. & Ceausu, E. INvestigation on antiganglioside antibodies in asymptomatic HIV patients. BMC Infect. Dis. 14(Suppl 4), P25 (2014).","journal-title":"BMC Infect. Dis."},{"key":"388_CR154","first-page":"808","volume":"80","author":"SG Degroote","year":"2015","unstructured":"Degroote, S. G., Gu, Y., Julien, S. & Delannoy, P. Gangliosides in breast cancer: new perspectives. Biochemistry 80, 808\u2013819 (2015).","journal-title":"Biochemistry"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-0388-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-0388-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-0388-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T18:17:36Z","timestamp":1744136256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-0388-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,9]]},"references-count":154,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["388"],"URL":"https:\/\/doi.org\/10.1038\/s41423-020-0388-9","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,9]]},"assertion":[{"value":"20 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}